Literature DB >> 22221101

Transient receptor potential vanilloid-1 participates in the inhibitory effect of ginsenoside Rg1 on capsaicin-induced interleukin-8 and prostaglandin E2 production in HaCaT cells.

Jin Huang1, Li Ding, Duo Shi, Jin-Hong Hu, Quan-Gang Zhu, Shen Gao, Lei Qiu.   

Abstract

OBJECTIVES: Ginsenoside Rg1 (GRg1), one of the major active constituents of Panax notoginseng, has shown anti-inflammatory and antinocioceptic activity, but its role in keratinocytes needs further study. We have examined the inhibitory effect of GRg1 on transient receptor potential vanilloid-1 (TRPV1) activation in keratinocyte HaCaT cells and explored its involved mechanism.
METHODS: HEK 293T cells over-expressing exogenous TRPV1 were constructed and named HEK 293T-TRPV1 cells. The effects of GRg1 on production of interleukin-8 (IL-8) and prostaglandin E(2) (PGE(2) ), calcium influx, the expression of cyclooxygenase-2 (COX-2) and nuclear factor-κB (NF-κB) transcriptional activity in HEK 293T-TRPV1 and HaCaT cells were examined by ELISA, Fluo 3-AM fluorescence probe, Western blot and Dual-Luciferase Reporter Assay, respectively. KEY
FINDINGS: The results showed that GRg1 blocked intracellular calcium by both capsaicin and proton activation in a TRPV1-dependent manner. Furthermore, GRg1 inhibited the expression of COX-2 and NF-κB transcriptional activity induced by capsaicin in keratinocytes. The inhibitory effect of GRg1 was similar to capsazepine, an antagonist of TRPV1. More importantly, GRg1 dose-dependently inhibited capsaicin-induced PGE(2) and IL-8 secretion in HaCaT cells and HEK 293T-TRPV1 cells.
CONCLUSIONS: These data showed that GRg1 could inhibit TRPV1 mediated responses in HaCaT cells, indicating that GRg1 acted as a TRPV1 antagonist.
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22221101     DOI: 10.1111/j.2042-7158.2011.01392.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.

Authors:  R M Helliwell; C O ShioukHuey; K Dhuna; J C Molero; J-M Ye; C C Xue; L Stokes
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

2.  An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases.

Authors:  Fang Li; Yan-ni Lv; Yi-sha Tan; Kai Shen; Ke-feng Zhai; Hong-Lin Chen; Jun-ping Kou; Bo-yang Yu
Journal:  Acta Pharmacol Sin       Date:  2015-10-12       Impact factor: 6.150

3.  The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis.

Authors:  Shichao Zheng; Yanling Zhang; Yanjiang Qiao
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-24       Impact factor: 2.629

4.  Protective effects of glycerol and xylitol in keratinocytes exposed to hyperosmotic stress.

Authors:  Edit Szél; Judit Danis; Evelin Sőrés; Dániel Tóth; Csilla Korponyai; Döníz Degovics; János Prorok; Károly Acsai; Shabtay Dikstein; Lajos Kemény; Gábor Erős
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-05-08

Review 5.  Progress on the Elucidation of the Antinociceptive Effect of Ginseng and Ginsenosides in Chronic Pain.

Authors:  Mei-Xian Li; Qian-Qi Wei; Huan-Jun Lu
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.